C2 PHARMA acquires Digoxin API portfolio from Nobilus Ent

Pharma/BioPharma |  News | 0 Comment | 19 Mar, 2019

C2 PHARMA s.a.r.l., a phytochemical and chemical pharmaceutical manufacturing and distribution group, has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent...Read more

Dr Reddy’s launches advanced service portal for customers

Pharma/BioPharma |  News | 0 Comment | 19 Mar, 2019

Dr. Reddy’s Laboratories Ltd. announces the launch of its advanced B2B Customer Service Portal “XCEED.” Fully focused on meeting the growing demand for Dr. Reddy’s p...Read more

Zydus set to market generic anti-diabetic drug

Pharma/BioPharma |  News | 0 Comment | 15 Mar, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies The company has received the tentative...Read more

AstraZeneca enters into research collaboration with Seres Therapeutics

Pharma/BioPharma |  News | 0 Comment | 13 Mar, 2019

Seres Therapeutics has announced a three-year research collaboration with AstraZeneca. The collaboration will focus on advancing mechanistic understanding of the microbiome in augmenti...Read more

Piramal launches Cinacalcet in the US market

Pharma/BioPharma |  News | 0 Comment | 12 Mar, 2019

Piramal Enterprises Limited has announced that one of its partners for its global pharma businesses - Slate Run Pharmaceuticals LLC. (‘Slate Run’), has launched generic cinacalc...Read more

West opens new digital technology centre in India

Pharma/BioPharma |  News | 0 Comment | 08 Mar, 2019

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has officially opened the Company’s new Digital Technology centre (DTC)...Read more

Lupin in alliance with Natco receives FDA approval for Imatinib Mesylate Tablets

Pharma/BioPharma |  News | 0 Comment | 06 Mar, 2019

Lupin and Natco Pharma has announced the final ANDA approval for Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base) from the United States Food and Drug Administration (FDA) to mark...Read more

IPA releases QF focused on Investigation of Non-conformities at IPF 2019

Pharma/BioPharma |  News | 0 Comment | 05 Mar, 2019

IPF 2019 started on a very somber note and with the sudden demise of Mr. D G Shah, Secretary General, IPA, the event lacked luster unlike the other previous events. In the last four years,...Read more

Janssen gets FDA nod for TREMFYA One-Press Patient-controlled Injector

Pharma/BioPharma |  News | 0 Comment | 01 Mar, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® One-Press, a single-dose, patient-con...Read more

Lynparza shows positive result in pancreatic cancer study

Pharma/BioPharma |  News | 0 Comment | 27 Feb, 2019

AstraZeneca and Merck announced positive results from the Phase III POLO trial. Results showed a statistically-significant and clinically-meaningful improvement in progression-free survival...Read more

Glenmark announces results from new analysis on Ryaltris™

Pharma/BioPharma |  News | 0 Comment | 26 Feb, 2019

Ryaltris (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), formerly GSP 301 Nasal Spray, is the company’s leading respiratory pipeline asset and currently under r...Read more

Dr Reddy's re-launches Buprenorphine, Naloxone Sublingual Film

Pharma/BioPharma |  News | 0 Comment | 21 Feb, 2019

Dr. Reddy’s Laboratories Ltd. has announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalen...Read more

Glenmark to present new analysis on Ryaltris at the AAAAI 2019

Pharma/BioPharma |  News | 0 Comment | 20 Feb, 2019

Glenmark Pharmaceuticals has announced upcoming presentations of pooled data from clinical studies of Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), ...Read more

India Ratings and Research maintains a stable outlook on the Indian pharmaceutical sector

Pharma/BioPharma |  Reports/white papers | 0 Comment | 19 Feb, 2019

India Ratings and Research (Ind-Ra) has maintained a stable outlook on the Indian pharmaceutical sector due to the expected recovery in margins, improved cash generation on the back of emer...Read more

Orit Lab gets USFDA nod for Fenofibrate Tablets

Pharma/BioPharma |  News | 0 Comment | 18 Feb, 2019

Alembic Pharmaceuticals Limited (Alembic) has announced that its wholly owned step down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (US...Read more

Glenmark receives ANDA approval for Clobetasol Propionate Foam

Pharma/BioPharma |  News | 0 Comment | 18 Feb, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05%, a generic version of Olux®...Read more

Lupin launches Clobazam Oral Suspension to treat seizures

Pharma/BioPharma |  News | 0 Comment | 18 Feb, 2019

Pharma major Lupin has announced the launch of Clobazam Oral Suspension, 2.5mg/mL, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin&rsqu...Read more

Glenmark to spin off its innovation business in US

Pharma/BioPharma |  News | 0 Comment | 15 Feb, 2019

Glenmark Pharmaceuticals has announced that its Board of Directors has given an in-principle approval to spin off the innovation business into a new company in the US. Setting up of the ne...Read more